Longitudinal Study Reveals Evolving Parkinson's Challenges

Wearable tech and patient-centered approach provide new insights into disease progression

Published on Mar. 11, 2026

Got story updates? Submit your updates here. ›

A new study funded by The Michael J. Fox Foundation and published in the Journal of Neurology has provided crucial insights into the evolving nature of Parkinson's disease (PD). The research, applauded by the Critical Path Institute (C-Path), followed participants for three years and revealed that functional impairment continues to worsen even when individual symptoms appear stable. The study leveraged wearable devices to gather data on participants' real-world experiences, offering a more comprehensive understanding of the disease's impact on quality of life.

Why it matters

This study highlights a significant shift in Parkinson's research, moving beyond a focus on specific symptoms to a more holistic assessment of the disease's progression and its impact on daily life. By incorporating patient perspectives and leveraging wearable technology, researchers can develop better tools to support drug development and ensure that clinical trials address the most pressing needs of individuals living with Parkinson's.

The details

The study found that gait, balance, and posture were particularly bothersome issues for individuals with early Parkinson's, and the effort required for everyday activities and the associated psychosocial burden also increased significantly over the three-year period. This suggests that the lived experience of Parkinson's extends beyond motor symptoms, impacting quality of life in profound ways. The research leveraged wearable devices to gather data on participants' real-world experiences, providing a distinct advantage over traditional clinical assessments that often take place in controlled environments.

  • The study followed participants for three years.
  • The research was published in the Journal of Neurology in 2026.

The players

The Michael J. Fox Foundation

A non-profit organization dedicated to finding a cure for Parkinson's disease and improving the lives of those affected by it.

Critical Path Institute (C-Path)

A non-profit organization that focuses on putting robust and patient-centered measurement tools in the hands of drug developers to improve clinical trial design.

University of Rochester Medical Center

A research institution that has conducted studies on the use of smartwatches for monitoring Parkinson's disease progression.

Dr. Jamie Adams

A researcher at C-Path who notes that the integration of patient perspectives is 'fundamentally changing how we approach clinical observation.'

Got photos? Submit your photos here. ›

What they’re saying

“The integration of patient perspectives is fundamentally changing how we approach clinical observation.”

— Dr. Jamie Adams, Researcher, Critical Path Institute (C-Path) (NationalToday.com)

What’s next

The study's findings highlight the need for continued research and collaboration between researchers, drug developers, and the Parkinson's community to ensure that clinical trials and treatment development address the most pressing needs of individuals living with the disease.

The takeaway

This study demonstrates the power of a patient-centered, technology-driven approach to Parkinson's research, providing a more comprehensive understanding of the disease's progression and its impact on daily life. By incorporating the patient voice and leveraging wearable devices, researchers can develop better tools to support drug development and improve the lives of those affected by Parkinson's.